TNF-α has tropic rather than apoptotic activity in human hematopoietic progenitors: Involvement of TNF receptor-1 and caspase-8

Stem Cells

Volumn 31, Issue 1, 2013, Pages 156-166

  Mizrahi, Keren ^a,b   Stein, Jerry ^a   Yaniv, Isaac ^b   Kaplan, Offer ^a   Askenasy, Nadir ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adult hematopoietic stem cells; Apoptosis; Mobilized peripheral blood; Tumor necrosis factor; Umbilical cord blood

Indexed keywords

CASPASE 8; CD34 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL STRESS; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; ENGRAFTMENT; ENZYME ACTIVATION; EX VIVO STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMOBILIZED CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PROTEIN FUNCTION; SEVERE COMBINED IMMUNODEFICIENCY; UMBILICAL CORD BLOOD;

ANIMALS; ANTIGENS, CD34; APOPTOSIS; CASPASE 8; CELLS, CULTURED; ENZYME ACTIVATION; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; MICE, SCID; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84871549632     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1259     Document Type: Article

References (71)

1. Nagata S. Apoptosis by death factor. Cell 1997;88:355-365. (Pubitemid 27131377)
2. Lenardo M, Chan KM, Hornung F et al. Mature T lymphocyte apoptosis - Immune regulation in a dynamic and unpredictable antigenic environment. Ann Rev Immunol 1999;17:221-253. (Pubitemid 29241124)
3. Niho Y, Asano Y. Fas/Fas ligand and hematopoietic progenitor cells. Curr Opin Hematol 1998;5:163-165. (Pubitemid 28360539)
4. Gaur U, Aggarwal BB. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 2003;66:1403-1408. (Pubitemid 38373326)
5. Testa U. Apoptotic mechanisms in the control of erythropoiesis. Leukemia 2004;18:1176-1199. (Pubitemid 39023128)
6. Rusten LS, Jacobsen FW, Lesslauer W et al. Bifunctional effects of tumor necrosis factor alpha (TNF alpha) on the growth of mature and primitive human hematopoietic progenitor cells: Involvement of p55 and p75 TNF receptors. Blood 1994;83:3152-3159. (Pubitemid 24158459)
7. Jacobsen FW, Veiby OP, Stokke T et al. TNF-alpha bidirectionally modulates the viability of primitive murine hematopoietic progenitor cells in vitro. J Immunol 1996;157:1193-1199.
8. Baxter GT, Kuo RC, Jupp OJ et al. Tumor necrosis factor-alpha mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression. J Biol Chem 1999;274:9539-9547.
9. Dybedal I, Yang L, Bryder D et al. Human reconstituting hematopoietic stem cells up-regulate Fas expression upon active cell cycling but remain resistant to Fas-induced suppression. Blood 2003;102:118-126. (Pubitemid 36759644)
10. Backx B, Broeders L, Bot FJ et al. Positive and negative effects of tumor necrosis factor on colony growth from highly purified normal marrow progenitors. Leukemia 1991;5:66-70.
11. Caux C, Favre C, Saeland S et al. Potentiation of early hematopoiesis by tumor necrosis factor-alpha is followed by inhibition of granulopoietic differentiation and proliferation. Blood 1991;78:635-644.
12. Caux C, Durand I, Moreau I et al. Tumor necrosis factor alpha cooperates with interleukin 3 in the recruitment of a primitive subset of human CD34+ progenitors. J Exp Med 1993;177:1815-1820. (Pubitemid 23146151)
13. Nagafuji K, Shibuya T, Harada M et al. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 1995;86:883-889.
14. Maciejewski J, Selleri C, Anderson S et al. Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 1995;85:3183-3190.
15. Takenaka K, Nagafuji K, Harada M et al. In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95). Blood 1996;88:2871-2877. (Pubitemid 26357367)
16. Beg AA, Baltimore D. An essential role for NF-α induced cell death. Science 1996;274:782-784.
17. Pyatt DW, Stillman WS, Yang Y et al. An essential role for NF-κB in human CD34+ bone marrow cell survival. Blood 1999;93:3302-3308. (Pubitemid 29220897)
18. Kerzic PJ, Pyatt DW, Zheng JH et al. Inhibition of NF-κB by hydroquinone sensitizes human bone marrow progenitor cells to TNF-α-induced apoptosis. Toxicology 2003;187:127-137. (Pubitemid 36423308)
19. Bárcena A, Park SW, Banapour B et al. Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver. Blood 1996;88:2013-2025. (Pubitemid 26307903)
20. Peters R, Leyvraz S, Perey L. Apoptotic regulation in primitive hematopoietic precursors. Blood 1998;92:2041-2052. (Pubitemid 28446694)
21. Kim H, Whartenby KA, Georgantas 3rd RW et al. Human CD34 Hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis. Stem Cells 2002;20:174-182. (Pubitemid 34297265)
22. Ratajczak J, Kucia M, Reca R et al. Quiescent CD34+ early erythroid progenitors are resistant to several erythropoietic 'inhibitory' cytokines; role of FLIP. Br J Haematol 2003;123:160-169. (Pubitemid 37222775)
23. Fukuda S, Pelus LM. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34 cells by hematopoietic growth factors: Implication of survivin expression in normal hematopoiesis. Blood 2001;98:2091-2100.
24. Wang L, Du F, Wang X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 2008;133:693-703. (Pubitemid 351636305)
25. Aggarwal BB. Signalling pathways of the TNF superfamily: A double- edged sword. Nat Rev Immunol 2003;3:745-756. (Pubitemid 41070815)
26. Dempsey PW, Doyle SE, He JQ et al. The signalling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev 2003;14:193-209. (Pubitemid 36693141)
27. Ware CF. The TNF superfamily. Cytokine Growth Factor Rev 2003;14:181-184.
28. Broxmeyer HE, Williams DE, Lu L et al. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: Synergism of tumor necrosis factor and interferon-gamma. J Immunol 1986;136:4487-4495. (Pubitemid 16090666)
29. Maguer-Satta V, Oostendorp R, Reid D et al. Evidence that ceramide mediates the ability of tumor necrosis factor to modulate primitive human hematopoietic cell fates. Blood 2000;96:4118-4123.
30. Dybedal I, Bryder D, Fossum A et al. Tumor necrosis factor (TNF)- mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells. Blood 2001;98:1782-1791.
31. Jacobsen FW, Rothe M, Rusten L et al. Role of the 75-kDa tumor necrosis factor receptor: Inhibition of early hematopoiesis. Proc Natl Acad Sci USA 1994;91:10695-10699. (Pubitemid 24329065)
32. Selleri C, Sato T, Anderson S et al. Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol 1995;165:538-546.
33. Zhang Y, Harada A, Bluethmann H et al. Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: Increase of early hematopoietic progenitor cells in TNF receptor p55- deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF alpha in vitro. Blood 1995;86:2930-2937.
34. Theus JW, Justus RS, Theus SA. A correlation between growth rate, apoptosis, and tumor necrosis factor-alpha in umbilical cord blood cells infected with two strains of Mycobacterium tuberculosis. Transfusion 2009;49:1720-1727.
35. Caux C, Saeland S, Favre C et al. Tumor necrosis factor-alpha strongly potentiates interleukin-3 and granulocyte-macrophage colony-stimulating factor-induced proliferation of human CD34+ hematopoietic progenitor cells. Blood 1990;75:2292-2298. (Pubitemid 20202305)
36. Sato T, Selleri C, Anderson S et al. Expression and modulation of cellular receptors for interferon-gamma, tumour necrosis factor, and Fas on human bone marrow CD34+ cells. Br J Haematol 1997;97:356-365. (Pubitemid 27224618)
37. Danet GH, Lee HW, Luongo JL et al. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion. Exp Hematol 2001;29:1465-1473. (Pubitemid 34007622)
38. Wang LS, Liu HJ, Xia ZB et al. Expression and activation of caspase- 3/CPP32 in CD34(+) cord blood cells is linked to apoptosis after growth factor withdrawal. Exp Hematol 2000;28:907-915.
39. Pearl-Yafe M, Mizrahi K, Stein J et al. Tumor necrosis factor receptors support murine hematopoietic progenitor function in the early stages of engraftment. Stem Cells 2010;28:1270-1280.
40. Mizrahi K, Stein J, Pearl-Yafe M et al. Regulatory functions of TRAIL in hematopoietic progenitors: Human umbilical cord blood and murine bone marrow transplantation. Leukemia 2010;24:1325-1334.
41. Vinci G, Chouaib S, Autran B et al. Evidence that residual host cells surviving the conditioning regimen to allogeneic bone marrow transplantation inhibit donor hematopoiesis in vitro-the role of TNF-alpha. Transplantation 1991;52:406-411.
42. Bryder D, Ramsfjell V, Dybedal I et al. Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation. J Exp Med 2001;194:941-952. (Pubitemid 32953263)
43. Pronk CJ, Veiby OP, Bryder D et al. Tumor necrosis factor restricts hematopoietic stem cell activity in mice: Involvement of two distinct receptors. J Exp Med 2011;208:1563-1570.
44. Rebel VI, Hartnett S, Hill GR et al. Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level. J Exp Med 1999;190:1493-1504.
45. Rezzoug F, Huang Y, Tanner MK et al. TNF-alpha is critical to facilitate hemopoietic stem cell engraftment and function. J Immunol 2008;180:49-57.
46. Pearl-Yafe M, Yolcu ES, Stein J et al. Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis. Exp Hematol 2007a;35:1601-1612. (Pubitemid 47419142)
47. Pearl-Yafe M, Yolcu ES, Stein J et al. Fas ligand enhances hematopoietic cell engraftment through abrogation of alloimmune responses and nonimmunogenic interactions. Stem Cells 2007;25:1448-1455. (Pubitemid 47106012)
48. Eaves C, Glimm H, Eisterer W et al. Characterization of human hematopoietic cells with short-lived in vivo repopulating activity. Ann N Y Acad Sci 2001;938:63-70.
49. Coulombel L. Identification of hematopoietic stem/progenitor cells: Strength and drawbacks of functional assays. Oncogene 2004;23:7210-7222. (Pubitemid 39382155)
50. Young JC, Lin K, Travis M et al. Investigation into an engraftment defect induced by culturing primitive hematopoietic cells with cytokines. Cytotherapy 2001;3:307-320. (Pubitemid 34784627)
51. Gothot A, van der Loo JCM, Clapp DW et al. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34 cells in non-obese diabetic/severe combined immune-deficient mice. Blood 1998;92:2641-2649. (Pubitemid 28469074)
52. Guenechea G, Segovia JC, Albella B et al. Delayed engraftment of nonobese diabetic severe combined immunodeficient mice transplanted with ex vivo expanded human CD34 cord blood cells. Blood 1999;93:1097-1105. (Pubitemid 29067876)
53. Glimm H, Oh IH, Eaves CJ. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/ M transit and do not reenter G(0). Blood 2000;96:4185-4193.
54. Jetmore A, Plett PA, Tong X et al. Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34 cells transplanted into conditioned NOD/SCID recipients. Blood 2002;99:1585-1593. (Pubitemid 34533030)
55. Pearl-Yafe M, Stein J, Yolcu ES et al. Fas transduces dual apoptotic and trophic signals in hematopoietic progenitors. Stem Cells 2007b;25:3194-203. (Pubitemid 350294445)
56. Drutskaya MS, Ortiz M, Liepinsh DJ et al. Inhibitory effects of tumor necrosis factor on hematopoiesis seen in vitro are translated to increased numbers of both committed and multipotent progenitors in TNF-deficient mice. Exp Hematol 2005;33:1348-1356. (Pubitemid 41540523)
57. Umland O, Heine H, Miehe M et al. Induction of various immune modulatory molecules in CD34(+) hematopoietic cells. J Leukoc Biol 2004;75:671-679. (Pubitemid 38405659)
58. Fernandez L, Rodriguez S, Huang H et al. Tumor necrosis factor-alpha and endothelial cells modulate Notch signaling in the bone marrow microenvironment during inflammation. Exp Hematol 2008;36:545-558.
59. Moreau G, Leite-De-Moraes M, Ezine S et al. Natural killer cell-dependent apoptosis of peripheral murine hematopoietic progenitor cells in response to Fas cross-linking: Involvement of tumor necrosis factor- alpha. Blood 2001;97:3069-3074.
60. Santiago-Schwarz F, Rappa DA, Laky K et al. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis. Stem Cells 1995;13:186-197.
61. Lardon F, Snoeck HW, Berneman ZN et al. Generation of dendritic cells from bone marrow progenitors using GM-CSF, TNF-alpha, and additional cytokines: Antagonistic effects of IL-4 and IFN-gamma and selective involvement of TNF-alpha receptor-1. Immunology 1997;91:553-559. (Pubitemid 27312337)
62. Gao Y, Tapper H, Calafat J et al. Granule targeting of soluble tumor necrosis factor (TNF) receptor expressed during granulopoietic maturation in murine bone marrow cells. Eur Cytokine Netw 2006;17:98-108.
63. Muller S, Rihs S, Dayer Schneider JM et al. Soluble TNF-α but not transmembrane TNF-α sensitizes T cells for enhanced activation-induced cell death. Eur J Immunol 2009;39:3171-3180.
64. Grell M, Douni E, Wajant H et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995;83:793-802.
65. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001;11:372-377. (Pubitemid 32900529)
66. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003;114:181-190. (Pubitemid 36936912)
67. Wilson NS, Dixit V, Ashkenazi A. Death receptor signal transducers: Nodes of coordination in immune signaling networks. Nat Immunol 2009;10:348-355.
68. Liu ZG, Hu H, Goeddel DV et al. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis, while NF-B activation prevents cell death. Cell 1996;87:565-576. (Pubitemid 26374329)
69. Van Antwerp DJ, Martin SJ, Kafri T et al. Suppression of TNF-induced apoptosis by NF-αB. Science 1996;274:787-789.
70. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 2002;3:221-227.
71. Secchiero P, Gonelli A, Mirandola P et al. Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway. Blood 2002;100:2421-2429.